Valuation (83%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 3.46 | 17.18 |
| PEG Ratio (TTM) | -2.44 | 6.12 |
| P/S Ratio (TTM) | 1.75 | 2.87 |
| P/B Ratio (TTM) | 0.95 | -4.82 |
| P/FCF Ratio (TTM) | 5.06 | 22.89 |
| Price to 5YR AVG Earnings Ratio | 11.56 | 34.27 |
| Price to 5YR AVG FCF Ratio | 12.34 | 20.33 |
Profitability (85%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 19.82% | 5.96% |
| ROE (TTM) | 28.21% | -676.88% |
| Net Profit Margin (TTM) | 50.91% | 17.27% |
| ROIC 5YR AVG | 12.30% | 9.02% |
Growth (42%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 1.68% | -739.11% | -369.80% |
| Revenue | 105.37% | 5.08% | 51.29% |
| Net Income | 1.95% | -933.99% | -474.09% |
| Cash Flow | -1.64% | 270.94% | 285.95% |
Health (81%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.60 | 1.03 |
| Quick Ratio (TTM) | 3.60 | 0.88 |
| D/E Ratio (TTM) | 0.35 | -2.67 |
| Interest Coverage (TTM) | 9.08 | 3.11 |
| Piotroski F-Score | 8 | 6 |
| Altman Z-Score | 2.98 | 1.65 |
| LTL to 5YR AVG FCF | 4.25 | 6.06 |
| Shares Outstanding Growth 5YR AVG | 12.10% | 8.95% |